Brad Rees
Chairman at G2 Therapies Pty Ltd.
Brad Rees active positions
| Companies | Position | Start | End |
|---|---|---|---|
G2 Therapies Pty Ltd.
 G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia. | Chairman | - | - |
Career history of Brad Rees
Former positions of Brad Rees
| Companies | Position | Start | End |
|---|---|---|---|
| Goldman Sachs & Partners (Australia) Pty Ltd. | President | - | 31/12/2006 |
The Garvan Institute of Medical Research
 The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia. | Director/Board Member | 21/06/2011 | - |
Statistics
International
| Australia | 4 |
Operational
| Director/Board Member | 1 |
| President | 1 |
| Chairman | 1 |
Sectoral
| Commercial Services | 2 |
| Finance | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
The Garvan Institute of Medical Research
The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia. | Commercial Services |
| Goldman Sachs & Partners (Australia) Pty Ltd. | Finance |
G2 Therapies Pty Ltd.
G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia. | Health Technology |
- Stock Market
- Insiders
- Brad Rees
- Experience
